Compounds > rb 101
Page last updated: 2024-09-03

rb 101 and l 365260

rb 101 has been researched along with l 365260 in 5 studies

Compound Research Comparison

Studies
(rb 101)		Trials
(rb 101)		Recent Studies (post-2010)
(rb 101)		Studies
(l 365260)		Trials
(l 365260)		Recent Studies (post-2010) (l 365260)
5702422108

Protein Interaction Comparison

ProteinTaxonomyrb 101 (IC50)l 365260 (IC50)
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.0081
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.0081
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.4981
Gastrin/cholecystokinin type B receptorRattus norvegicus (Norway rat)0.039
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0081
Histamine H1 receptorCavia porcellus (domestic guinea pig)5
Cholecystokinin receptor type AHomo sapiens (human)0.1585
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.0079
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)5
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.044
Cysteinyl leukotriene receptor 2Homo sapiens (human)5
Cysteinyl leukotriene receptor 1Homo sapiens (human)5

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O1
Derrien, M; Maldonado, R; Noble, F; Roques, BP1
Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Smadja, C; Turcaud, S1
Blommaert, AG; Fournié-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O1
Fournié-Zaluski, MC; Fuentes, JA; Hernando, F; Roques, BP; Ruiz-Gayo, M1

Other Studies

5 other study(ies) available for rb 101 and l 365260

ArticleYear
Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:1

    Topics: Adamantane; Analgesics; Animals; Benzodiazepinones; Dipeptides; Disulfides; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Nociceptors; Pain Measurement; Phenylalanine; Phenylurea Compounds; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Regression Analysis; Tail

1994
Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
    Neuroreport, 1993, Volume: 4, Issue:7

    Topics: Analgesics; Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Disulfides; Drug Synergism; Male; Mice; Pain Measurement; Phenylalanine; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Cholecystokinin

1993
Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
    Psychopharmacology, 1995, Volume: 120, Issue:4

    Topics: Analgesics; Animals; Antidepressive Agents; Benzodiazepinones; Cholecystokinin; Disulfides; Enkephalins; Male; Mice; Mice, Inbred Strains; Motor Activity; Peptide Fragments; Phenylalanine; Phenylurea Compounds; Receptors, Cholecystokinin

1995
Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
    European journal of pharmacology, 1995, Nov-03, Volume: 286, Issue:1

    Topics: Analgesics; Animals; Benzodiazepinones; Disulfides; Drug Synergism; Drug Tolerance; Indoles; Male; Meglumine; Mice; Pain Measurement; Phenylalanine; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Time Factors

1995
Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    European journal of pharmacology, 1996, Dec-30, Volume: 318, Issue:2-3

    Topics: Animals; Antidepressive Agents; Benzodiazepinones; Devazepide; Disulfides; Endorphins; Male; Mice; Naloxone; Naltrexone; Phenylalanine; Phenylurea Compounds; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide

1996